Authors/Disclosures
|
Masako Kinoshita, MD, PhD
(8 Ondoyamacho)
|
Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka Pharmaceutical Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan Co. Ltd. . Dr. Kinoshita has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo Company, Limited.. The institution of Dr. Kinoshita has received research support from Japan Society for the Promotion of Science. The institution of Dr. Kinoshita has received research support from Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering . |
|
Abhinav Raina, MD, MBBS
(Manipal hospital Whitefield)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Riki Matsumoto, MD, PhD
(Department of Neurology, Kyoto University Graduate School of Medicine)
|
Dr. Matsumoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Dr. Matsumoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB Japan. Dr. Matsumoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. Matsumoto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ostuka. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Akio Ikeda, MD
(Kyoto University Hospital)
|
Dr. Ikeda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Japan. Dr. Ikeda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo pharms. The institution of Dr. Ikeda has received research support from sumitomo pharma. The institution of Dr. Ikeda has received research support from UCB Japan. The institution of Dr. Ikeda has received research support from Nihon Kohden. The institution of Dr. Ikeda has received research support from Eli Lilly. The institution of Dr. Ikeda has received research support from Richo. |